Please use this identifier to cite or link to this item:
http://111.93.178.142:25000/jspui/handle/123456789/5074Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Vidya Jyothi Alli | - |
| dc.date.accessioned | 2026-06-03T11:00:00Z | - |
| dc.date.available | 2026-06-03T11:00:00Z | - |
| dc.date.issued | 2026-06-03 | - |
| dc.identifier.uri | http://111.93.178.142:25000/jspui/handle/123456789/5074 | - |
| dc.description | Vol. 64 No. 1, p 22 | en_US |
| dc.language.iso | en | en_US |
| dc.subject | Dynamics | en_US |
| dc.subject | In silico ADMET study | en_US |
| dc.subject | In silico target prediction | en_US |
| dc.subject | Pharmacophore | en_US |
| dc.subject | Rosiglitazone | en_US |
| dc.title | Ligand based pharmacophoric discovery of new CLK1 inhibitors | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Vol. 64 No. 1, 2025 | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.